Pharmacy benefit management

The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.

As the Trump administration pledges to bring down America’s high-and-rising drug prices, workers are living with the burden of costly medications.

By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.

The president will propose a sweeping effort to bring down U.S. drug prices in a plan to make good on a campaign promise.

The price of prescriptions has skyrocketed and the industry needs to address matters sooner rather than later.

The price of prescriptions has skyrocketed and the industry needs to address matters sooner rather than later.

Many pharmacy benefit managers promote discounts and drug rebates that may look good on paper, but often provide no transparency of true costs. This can result in employers paying much more than they should.

Many pharmacy benefit managers promote discounts and drug rebates that may look good on paper, but often provide no transparency of true costs. This can result in employers paying much more than they should.